Fitness Trackers Might Help Predict Multiple Sclerosis Progression
via HealthDayTHURSDAY, March 5, 2026 — Wrist-worn fitness tracking devices might be able to predict whether a person with multiple sclerosis is more likely to have worsening disability, a new study says.
Data from fitness trackers showed not only who was at higher risk of disease progression, but whose brains might be in danger of deterioration, researchers reported March 4 in the journal Neurology.
“Timely identification of patients at risk for disease progression is essential to reduce long-term disability, but the current tests for measuring MS disability are not designed to detect small changes,” said lead researcher Kathryn Fitzgerald, an assistant professor of neurology and epidemiology with Johns Hopkins University in Baltimore.
“Using a relatively inexpensive and accessible device around the wrist may help us identify early changes in the disease,” she said in a news release.
For the study, researchers equipped 238 people with MS with a fitness tracker that measured how much physical activity they had during the day, how much time they spent sitting or inactive, as well as their sleep cycles.
Participants were asked to wear the devices around the clock for two weeks, and they repeated the process every three months for an average of three years.
During the study, 120 people had their MS progress, and their physical activity patterns reflected those at higher risk, researchers said.
Specifically, people who had decreased activity during the first half of the day were 20% more likely to have their MS grow worse than those who had no decreases in their activity level, the study found.
Declines in morning activity levels also were linked to brain atrophy among MS patients, with decreases in whole brain volume, gray matter and the thalamus – a brain structure that processes sensory and motor information.
“More research is needed to confirm these findings, but it’s exciting to think that using easily accessible devices could help us predict who is at risk of worsening disease and potentially prevent those changes,” senior researcher Dr. Ellen Mowry, director of neuroimmunology and neurological infections at Johns Hopkins University, said in a news release.
“Detecting small changes could also help us speed up research on new treatments,” she said.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-03-06 02:13
Read more
- FDA Approves Dupixent for Allergic Fungal Rhinosinusitis
- AAAAI: Peanut Allergy Risk Increased in Younger Siblings of Peanut-Consuming Children
- FDA To Offer Cash Bonuses for Faster Drug Reviews
- FDA Approves Hernexeos, the First Targeted Therapy for Adults with HER2-Mutant Advanced NSCLC as an Initial Treatment Option
- Firearm Injuries Tied to Long-Term Physical, Functional Health Challenges
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions